Emerging technologies for accelerated toxicity evaluation of potential drug candidates

Current Opinion in Drug Discovery and Development

Volumn 2, Issue 1, 1999, Pages 58-68

  Todd, Marque D ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ACYL COENZYME A; ALKALINE PHOSPHATASE; BETA ACTIN; BETA GALACTOSIDASE; CALBINDIN; CARCINOGEN; CHLORAMPHENICOL ACETYLTRANSFERASE; CISPLATIN; CYCLOSPORIN A; CYTOCHROME P450; DNA; DNA B; DRUG; ETHOXYRESORUFIN DEETHYLASE; GENE PRODUCT; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; INSULIN; LUCIFERASE; MESSENGER RNA; PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

DRUG INDUSTRY; DRUG SAFETY; FLUORESCENCE POLARIZATION; GENE EXPRESSION; GENOME; HUMAN; HYBRIDIZATION; ISOELECTRIC FOCUSING; MASS SPECTROMETRY; MODEL; NONHUMAN; POLYMERASE CHAIN REACTION; PROTEIN ANALYSIS; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SCINTILLATION; TECHNOLOGY; TOXICITY; TWO DIMENSIONAL ELECTROPHORESIS;

EID: 0032901566     PISSN: 13676733     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (103)

1. Monro AM: Why do so many drugs fail between the laboratory and the marketplace? In: The Use of Human In Vitro Systems to Support Preclinical and Clinical Safety Assessment. Sundwall A, Alvan G, ündgren E, Moldeus P, Salmonsson T, Sjoberg P (Eds), Tryckgruppen Press, Sweden (1997) 1-4.
2. Ulrich RG, Cramer CT, Sun EL, Bacon JA, Petrella DK: A protocol for Isolation, culture and cryopreservation of hepatocytes from human liver. In Vitro Mol Tox'cd (1998) 11:23-33.
3. Adams RM, Wang M, Crane AM, Brown B, Darlington GJ, Ledley FD: Effective cryopreservation and long-term storage of primary human hepatpcytes with recovery of viability, differentiation, and replicative potential. Cell Transplant (1995)4:579-586.
4. Ferrini JB, Richard L, Domergue J, Maurel P: Long-term primary cultures of adult human hepatocytes. Chem Biol Interact (1997) 107:31 -45.
5. Strom SC, Pisarov LA, Dorko K, Thompson MT, Schuetz JD, Schuetz EG: Use of human hepatocytes to study P450 gene induction. Methods Enzymo/(1996) 272:388-401.
6. An excellent methods paper describing both human hepatocyte culture and induction ofcytochrome P450.
7. Li AP, Maurel P, Gomez-Lechon MJ, Cheng LC, Jurima-Romet M: Prelinical evaluation of drug-drug interaction potential: present status of the application of primary human hepatocytes in the evaluation of cytocnrome P450 induction. Chem Biol Interact (1997) 107:5-16.
8. Bertilsson G, Heidrich J, Svensson K, Asman M, Jendeberg L, Sydow-Bäckman M, Ohlsson R, Postlind H, Blomquist P, Berkenstam A: Identification of a human nuclear receptor defines a new signaling pathway for CYP3A induction. Proc NatlAcad Sci USA (1998) 95:12208-12213.
9. This paper describes an important development in understanding how cytocnrome P450 levels may be regulated, and thus an important development for understanding drug-drug interactions.
10. Lehmann JM, McKee DD, Watson MA, Willson TM, Moore JT, Kliewer SA: The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions. J Clin Invest (1998)102:1016-1023.
11. Kliewer SA, Moore JT, Wade L, Staudinger JL, Watson MA, Jones SA, McKee DD, Oliver BB, Willson TM, Zetterstrom RH, Perlmann T, Lehmann JM: An orphan nuclear receptor activated by pregnanes defines a novel steroid signaling pathway. Cell (1998) 92:73-82.
12. Ulrich RG: Utility of cultured human hepatocytes in drug discovery and development In: Use of Human In Vitro Systems to Support Preclinical and Clinical Safety Assessment. Sundwall A, Alvan G, Lindgren E, Moldeus P, Salmonsson T, Sjoberg P (Eds), Tryckgruppen Press, Sweden (1997) 105-110.
13. Guillouzo A: Liver cell models in in vitro toxicology. Environ Health Perspect (1998) 106:511-532.
14. Schena M, Shalon D, Davis RW, Brown PO: Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science (1995) 270:467-470.
15. Ramsay G: DNA chips: state-of-the art. Nature Biotechnol (1998)16:40-44.
16. A comprehensive overview of microarray technology.
17. Schena M, Heller RA, Theriault TP. Konrad K, Lachenmeier E, Davis RW: Microarrays: biotechnology's discovery platform for functional genomics. Trends Biotechnol (1997) 16:301-306.
18. Schena M, Shalon D, Heller R, Chai A, Brown PO, Davis RW: Parallel human genome analysis: microarray-based expression monitoring of 1000 genes. P roc Natl Acad Sci USA (1996) 93:10614-10619.
19. An intriguing paper showing the practical application of microarrays containing 1046 human cDNAs which were screened using two-color hybridization for heat-shock and phorbol esterinduced genes.
20. Heller RA, Schena M, Chai A, Shalon D, Bedilion T, Gilmore J, Woolley DE, Davis RW: Discovery and analysis of inflammatory disease-related genes using cDNA microarrays. Pmc Natl Acad Sci USA (1997) 94:2150-2155.
21. This work is similar to reference 44, but compared tissue samples of rheumatoid arthritis and inflammatory bowel disease.
22. DeRisi J, Penland L, Brown PO, Bittner ML, Meltzer PS, Ray M, Chen Y, Su YA, Trent JM: Use of a cDNA microarray to analyze gene expression patterns in human cancer. Nat Genet (1996) 14:457-460.
23. Milosavljevic A, Savkovic S, Crkvenjakov R, Salbego D, Serrato H, Kreuzer H, Gemmell A, Batus S, Grujic D, Camahan S, Paunesku T, Tepavcevic J: DNA sequence recognition by hybridization to short oligomers: experimental verification of the method on the E coli genome. Genomics (1996) 37:77-86.
24. DeRisi JL, lyer VR, Brown PO: Exploring the metabolic and genetic control of gene expression on a genomic scale. Science (1997) 278:680-686.
25. Wodicka L, Dong H, Mittmann M, Ho M-H, Lockhart DJ: Genome-wide expression monitoring in Saccharomyces cerevisiae. Nature Biotechnol (1997) 15:1359-1367.
26. This is one of the original papers introducing the concept and applications of microarrays.
27. Velculescu VE, Zhang L, Vogelstein B, Kinzler KW: Serial analysis of gene expression. Science (1995) 270:484-487.
28. Zhang L, Zhou W. Velculescu VE, Kern SE, Hruban RH, Hamilton SR, Vogelstein B, Kinzler KW: Gene expression profiles in normal and cancer cells. Science (1997) 276:1268-1272.
29. Madden SL, Galella EA, Zhu J, Bertelsen AH, Beaudry GA: SAGE transcript profiles for p53-dependent growth regulation. Oncogens (1997) 15:1079-1085.
30. Anderson L, Scilhamer J: A comparison of selected mRNA and protein abundances in human liver. Electrophoresis (1997) 18:533-537.
31. Excellent comparison of gene expression by analysis of mRNA compared to protein, illustrating the many differences in data between the approaches.
32. O'Farrell PH: High resolution two-dimensional electrophoresis of proteins. J Biol Chem (1975) 250:4007-4021.
33. Klose J: Protein mapping by combined isoelectric focusing and electrophoresis of mouse tissues. A novel approach to testing for induced point mutations in mammals. Humangenetik (1975) 26:231-243.
34. Humphery-Smith l, Cordwell SJ, Blackstock WP: Proteome research: complementarity and limitations with respect to the RNA and DNA worlds. Electrophoresis (1997) 18:1217-1242.
35. An outstanding review of 2-D electrophoresis and protein identification techniques with perspective to DNA sequence.
36. Haynes PA, Gygi SP, Figeys D, Aebersold R: Proteome analysis: biological assay or data archive? Electrophoresis (1998)19:1862-1871.
37. An interesting perspective on the utility of data derived from proteome analysis. Should be read along with the paper by Anderson and Anderson in this volume [29].
38. Anderson NL, Anderson NG: Proteome and proteomics: new technologies, new concepts, and new words. Electrophoresis (1998) 19:1853-1861.
39. An interesting perspective on the utility of data derived from proteome analysis.
40. Figeys D, Gygi SP, Zhang Y, Watts J, Gu M, Aebersold R: Electrophoresis combine with novel mass spectrometry techniques: Powerful tools for the analysis of proteins and proteomes. Electrophoresis (1998) 19:1811-1818.
41. Klose J, Kobalz U: Two-dimensional electrophoresis of proteins: an updated protocol and implications for a functional analysis of the genome. Electrophoresis (1995) 16:1034-1059.
42. Staudenmann W, Halt PD, Roving S, Lehmann A, Kertesz M, James P: Sample handling for proteome analysis. Electrophoresis (1998) 19:901-908.
43. This paper describes methods and concepts that are essential for maximizing signal for 2-D electrophoresis.
44. Rabilloud T, Kieffer S, Procaccio V, Louwagie M, Courchesne PL, Patterson SD, Martinez P, Garin J, Lunardi J: Twodimensional electrophoresis of human placenta) mitochondria and protein identification by mass spectrometry: toward a human mitochondrial proteome. Electrophoresis (1998) 19:1006-1014.
45. Yates JR: Mass spectrometry and the age of the proteome. J Mass Spectrom (1998) 33:1 -19.
46. An outstanding review of mass spectrometry techniques as applied to protein analysis.
47. Traini M, Gooley AA, Ou K, Wilkins MR, Tonella L, Sanches JC, Hochstrasser DF, Williams KL: Towards an automated approach for protein identification in proteome projects. Electrophoresis (1998) 19:1941 -1949.
48. Ostergaard M, Rasmussen HH, Nielsen HV, Vorum H, Omtoft TF, Wolf H, Cells JE: Proteome profiling of bladder squamous cell carcinomas: Identification of markers that define their degree of differentiation. Cancer Res (1997) 57:4111-4117.
49. Anderson NL, Taylor J, Hofmann JP, Esquer-Blasco R, Sweift S, Anderson NQ: Simultaneous measurement of hundreds of liver proteins: application in assessment of liver function. Toxical Pathol (1996) 24:72-76.
50. A brief but interesting overview ofproteome analysis as applied to an important target tissue.
51. Aicher L, Wahl D, Arce A, Grenet O, Steiner S: New insights into cyclosporine A nephrotoxicity by proteome analysis. Electrophoresis (1998) 19:1998-2003.
52. An excellent paper describing the application of proteome analysis to toxicology evaluation.
53. Amott D, O'Connell KL, King KL, Stults JT: An integrated approach to proteome analysis: identification of proteins associated with cardiac hypertrophy. Anal Biochem (1998) 258:1-18.
54. Dhundale A, Goddard C: Reporter assays in the highthroughput screening laboratory: a rapid and robust first look? J Biomol Screening (1996) 1:115-118.
55. Suto CM, Ignar DM: Selection of an optimal reporter gene for cell-based high-throughput screening assays. J Biomol Screening (1997) 2:7-9.
56. Bronstein I, Fortin J, Stanley E, Stewart GSAB, Kricka LJ: Chemiluminescent and bioluminescent reporter gene assays. Anal Biochem (1994) 219:169-181.
57. A definitive overview of Chemiluminescent substrates and procedures.
58. Rakhmanova VA, MacDonald RC: A microplate fluorimetric assay for transfection of the -galactosidase reporter gene. Anal Biochem (1998) 257:234-237.
59. Cullen BR, Malim MH: Secreted placental alkaline phosphatase as a eukaryotic reporter gene. In: Methods in Enzymology. Wu R (Ed), Academic Press, San Diego (1992) 362-368.
60. Misteli T, Spector DL: Applications of the green fluorescent protein in cell biology and biotechnology. Nature Biotechnol (1997)15:961-964.
61. A review focusing on the newest reporter gene, green fluorescent protein. It covers the structure and biology of GFP, but most importantly, the applications.
62. Todd MD, Lee MJ, Williams JL, Nalezny JM, Gee P, Benjamin MB, Farr SB: The CAT-Tox (L) assay: a sensitive and specific measure of stress-induced transcription in transformed human liver cells. Fundam Appl Toxicol (1995) 28:118-128.
63. Beard SE, Capaldi SR, Gee P: Stress responses to DNA damaging agents in the human colon carcinoma cell line, RKO. Mutat Res (1996) 371:1-13.
64. An interesting example of how reporter gene technology can be used to increase the amount of molecular information obtained about DNA damaging compounds.
65. Lee MJ, Gee P, Beard SE: Detection of peroxisome proliferators using a reporter construct derived from the rat acyl-CoA oxidase promoter in the rat liver cell line H-4-II-E. Cancer Res (1997) 57:1575-1579.
66. A useful report on using a stably transfected cell line to detect and rank potential peroxisome proliferators.
67. Sanderson JT, Aarts JM, Brouwer A, Froese KL, Denison MS, Giesy JP: Comparison of Ah receptor-mediated luciferase and ethoxyresorufin-O-deethylase induction in H4IIE cells: implications for their use as bioanalytical tools for the detection of polyhalogenated aromatic hydrocarbons. Toxicol Appl Pharmcol (1996) 137:316-325.
68. Ourtin JC, Vilarem MJ, Daujat M, Harricane MC, Domergue J, Joyeux H, Baulieux J, Maurel P: Lipid-mediated transfection of normal adult human hepatocytes in primary culture. AnalBiochem (1997) 247:34-44.
69. Backers T, Reiländer H, Hilgard P: Characterization of gonadotropin-releasing hormone analogs based on a sensitive cellular luciferase reporter gene assay. Anal Biochem (1997) 251:17-23.
70. Williard R, Jammalamadaka V, Zava D, Benz CG, Hunt CA, Kushner PJ, Scanlan TS: Screening and characterization of estrogenic activity from a hydroxystilbene library. Chem Biol (1995) 2:45-51.
71. Pasapera AM, Camacho-Arroyo I, Savouret JF, Garcia GA, Perez-Palacios G, Pichon C, Cerbon MA: In vitro molecular assessment of the mechanisms of action of 19-nor progestins used as contragestational agents. Arch Mod Res (1995) 26:3203-3207.
72. Kawasaki ES, Wang AM: Detection of gene expression. In: PCR Technology. Ertich HA (Ed), Stockton Press, New York (1989)89-97.
73. Delassus 3: Quantification of cytokine transcripts using polymerase chain reaction. Eur Cytokine A/e(iv(1997) 8:239244.
74. A detailed review on optimizing, using and trouble-shooting quantitative RT-PCR techniques.
75. Mattes WB, Li AP: Quantitative reverse transcriptase/PCR assay for the measurement of induction in cultured hepatocytes. Chem Biol Interact (1997) 107:47-61.
76. Willey JC, Coy EL, Frampton MW, Torres A, Apostolakos MJ, Hoehn G, Schuermann WH, Thilly WG, Oison DE, Hammersley JR, Crespi CL, Utell MJ: Quantitative RT-PCR measurement of cytochromes P450 1A1, 1B1, and 2B7, microsomal epoxide hydrolase, and NADPH oxidoreductase expression in lung cells of smokers and nonsmokers. Am J Respir Ceil Mol Biol (1997) 17:114-124.
77. Holland P, Abramson RD, Watson R, Gelfand DH: Detection of specific polymerase chain reaction product by utilizing the 5'-3' exonuclease activity of Thermus aquaticus DNA polymerase. Proc Natl Acad Sci USA (1991) 88:7276-7280.
78. Held CA, Stevens J, Livak KJ, Williams PM: Real time quantitative PCR. Genome Res (1996) 6:986-994.
79. Gibson DEM, Held CA, Williams PM: A novel method for real time quantitative RT-PCR. Genome Res (1996) 6:995-1001.
80. The seminal publication on real time quantitative RT-PCR using TaqMan probe technology.
81. Suryanarayana K, Wiltrout TA, Vasquez GM, Hirsch VM, Lifson JD: Plasma SIV RNA viral load determination by real-time quantification of product generation in reverse transcriptase-polymerase chain reaction. AIDS Res Hum Retroviruses (1998) 14:183-189.
82. Petrik J. Pearson GJ, Allain JP: High-throughput PCR detection of HCV based on semiautomated multisample RNA capture. J Virol Methods (1997) 64:147-159.
83. This is a practical example of optimizing quantitative RT-PCR for high-throughput screening.
84. Kalinina O, Lebedeva I, Brown J, Silver J: Nanoliter scale PCR with TaqMan detection. Nucleic Acids Res (1997) 25:1999-2004.
85. Bosworth N, Towers P: Scintillation proximity assay. Nature (1989)341:167-168.
86. Hart HE, Greenwald EB: Scintillation proximity assay (SPA) - a new method of immunoassay. Direct and inhibition mode detection with human albumin and rabbit antihuman albumin. Mol Immunot (1979) 16:265-267.
87. Use of Flash Plate for live cell assays. In: FLASH NEWS, DuPont/NEN Products Life Science Products (1995).
88. Harris DW, Kenrick MK, Pither RJ, Anson JG, Jones DA: Development of a high-volume in situ mRNA hybridization assay for the quantification of gene expression utilizing scintillating microplates. AnalBiochem (1996) 243:249-256.
89. Kenrick MK, Jiang L, Potts CL, Owen PJ, Shuey DJ, Econome JG, Anson JG, Quinet EM: A homogeneous method to quantify mRNA levels: a hybridization of RNase protection and scintillation proximity assay technologies. Nucleic Acids Res (1997) 25:2947-2948.
90. Simpson PR, Yu XH, Redza ZM, Anson JG, Chan SH, Lin Y: Quantification of hepatitis B virus DNA using competitive PCR and a scintillation proximity assay. J Virol Methods (1997)69:197-208.
91. Lemer CG, Carter CD: PCR colony screening using the scintillation proximity assay to detect inserts in cloning vectors. BioTechniques (1995) 19:914-917.
92. Wilber JC: Branched DNA for quantification of viral load. Immunol Invest (1997) 26:9-13.
93. Roth WK, Lee JH, Rüster B, Zeuzem S: Quantification of hepatitis C virus RNA by RT-PCR in comparison to the branched DNA method. Z Gastroenterol (1998) 36:5-11.
94. Todd MD, Ludtke DN, Oshidari F, Johnson D, Wolfgang GHI: The utility of branched DNA (bDNA) assays in high-throughput toxicity screening. In: Approaches to High-throughput Screening in Toxicity Testing. Atterwill CK, Goldfarb M, Purcoll WM (Eds), Taylor & Francis Ltd, London, in press.
95. This chapter gives detailed information on the bDNA assay, including performance characteristics and examples of the assay used for toxicity testing.
96. Shen L, Sheridan P, Cao WW, Dailey PJ, Salazar-Gonzalez JF, Breen EC, Fahey JL, Urdea MS, Kolberg JA: Quantification of cytokine mRNA in peripheral blood mononuclear cells using branched DNA (bDNA) technology. J ImmunolMethods, in press.
97. Wang J, Shen L, Najafi H, Kolberg J, Matschinsky FM, Urdea M, German M: Regulation of insulin preRNA splicing by glucose. Proc NatlAcadSci USA (1997) 94:4360-4365.
98. An interesting article showing the sensitivity and specificity of the bDNA assay.
99. Hill DC: Trends in the development of high-throughput screening technologies for rapid discovery of novel drugs. Curr Opin Drug Discov Dev (1998) 1:92-97.
100. Murakami A, Nakaura M, Nakatsuji Y, Nagahara S, Tran-Gong QT, Makino K: Fluorescent-labeled oligonucleotide probes: detection of hybrid formation in solution by fluorescence polarization spectroscopy. Nucleic Acids Res (1991) 19:4097-4102.
101. Lopez E, Chypre C, Alpha B, Mathis G: Europium(lll) trisbipyridine cryptate label for time-resolved fluorescence detection of polymerase chain reaction products fixed on a solid support Clin Chem (1993) 39:196-201.
102. Zlokarnik G, Negulescu PA, Knapp TE, Mere L, Burres N, Feng L, Whitney M, Roemer K, Tsien RY: Quantitation of transcription and clonal selection of single living cells with -lactamase as reporter. Science (1998) 279:84-88.
103. The authors describe the use of a new membrane-permeant reagent for assaying β-lactamase in conjunction with a 96-well plate based fluorescent assay.